Takeda Pharmaceutical Company (OTCPK:TKPYY -4.6%) is down on light volume in early trade. Shares are currently exchanging hands at a 52-week low as it advances its planned $62B takeout of Shire plc, expected to close in the next few weeks.
Yesterday, Moody's downgraded its credit rating to Baa2 with a stable outlook.
Now read: Elekta: Blame It On Unity »
Subscribe for full text news in your inbox